Mr. Papa has been serving on the Board of
Directors for Bausch Health Companies Inc. since May 2016 as Chairman and Chief
Executive Officer. He has more than 35 years of experience in the pharmaceutical,
health care and specialty pharmaceutical industries, including more than 20 years of
branded prescription drug experience.
Prior to Bausch Health, he was the Chief Executive Officer of the
Perrigo Company from 2006 to April 2016. Before that, Papa served as Chairman and
Chief Executive Officer of Cardinal Health’s Pharmaceutical Technologies and
Services business unit (2004 – 2006). He was President and Chief Operating Officer
for Watson Pharmaceuticals (2001 – 2004), President of Global Country Operations for
Pharmacia’s North American business (2000 – 2001) and President of Searle’s U.S.
Operations (1997 – 2000). Prior to Searle/Pharmacia, Papa served in a variety of
general management, sales, marketing and R&D positions during his 15-year career
at Novartis Pharmaceuticals Corporation (1983 – 1997). During his career, he
led teams that successfully launched several blockbuster pharmaceutical products,
including Lotrel, Diovan and Celebrex, and he is the patent holder for a
cardiovascular combination treatment containing Amlodipine and Benazepril.
In October 2014, Harvard Business Review ranked Papa
47th on its “2014 Best Performing CEOs in the World.” list. He was also recognized
on Israel-based Calcalist Magazine’s “Best Chief Executive
Officer for the Year” list for 2013 and 2014. Additionally, Papa was named one of
the World’s Best CEOs by Barron’s magazine in 2012, which noted
Perrigo “generated one of the best shareholder returns in the S&P 500 in the
past five years.”
He is a past member of the UConn Foundation Board of Directors and the
Smith & Nephew Board of Directors, where he served as Chairman of the
Papa holds a B.S. in pharmacy from the University of Connecticut and an
MBA from Northwestern University’s Kellogg Graduate School of Management. In 2012,
he received an Honorary Doctor of Science degree from the University of
Connecticut’s School of Pharmacy.